marketcaparena
Search

    NTHI

    NEONC TECHNOLOGIES HOLDINGS, INC.

    Company overview

    Market capitalization
    $81.96M
    Employees
    5
    Latest publication
    2026-09-29
    About NEONC TECHNOLOGIES HOLDINGS, INC.

    NeOnc Technologies Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies. Its lead product candidates include NEO100, a purified form of preillyl acid that is in Phase IIa clinical trial; and NEO212, a covalently conjugated molecule combining chemotherapeutic drug temozolomide with perillyl alcohol that is in Phase I/II clinical trials for its oral administration for the treatment of primary brain cancers, such as meningioma, high grade gliomas, glioblastoma, and secondary brain cancers. The company was formerly known as NAS-ONC, Inc. and changed its name to NeOnc Technologies Holdings, Inc. in 2009. The company was incorporated in 2005 and is headquartered in Calabasas, California.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue0USD0USD0USD0USD0USD39,990USD20,000USD0USD
    Research Development2,649,673USD1,286,336USD1,247,665USD715,038USD677,332USD998,222USD1,079,513USD956,725USD
    Selling General Administrative895,559USD4,409,326USD12,399,257USD902,985USD984,262USD24,880,775USD1,037,969USD740,462USD
    General And Administrative Expenses895,559USD———————
    Total Operating Expenses14,069,887USD7,023,682USD13,696,922USD6,934,647USD5,708,034USD37,616,803USD2,133,732USD2,172,187USD
    Operating Income-14,069,887USD-7,055,662USD-13,696,922USD-6,934,647USD-5,708,034USD-37,576,813USD-2,113,732USD-2,172,187USD
    Total Other Income Expense Net-189,627USD-1,764,270USD-1,827,182USD-1,681,273USD27,864USD-425,174USD-139,250USD-12,313USD
    Interest Income334USD5,196USD205USD6,815USD28,725USD51,699USD3,446USD12,687USD
    Interest Expense234,370USD1,174,789USD478,769USD1,307,926USD240,999USD476,873USD142,696USD0USD
    Labor And Related Expense268,797USD———————
    Net Income-14,240,044USD-8,819,932USD-15,524,104USD-8,615,920USD-5,680,170USD-38,001,987USD-2,252,982USD-2,184,500USD
    Cost Of Revenue—31,980USD—18,308USD————
    Gross Profit—-31,980USD—-18,308USD—39,990USD20,000USD—
    Unclassified Operating Expenses—1,328,020USD—5,316,624USD4,046,440USD11,737,806USD——
    Net Interest Income—-1,169,593USD-1,589,048USD-1,301,111USD-212,274USD-425,174USD-139,250USD12,687USD
    Income Before Tax—-8,819,932USD-15,524,104USD-8,615,920USD-5,680,170USD-38,001,987USD-2,252,982USD-2,184,500USD
    Net Income From Continuing Ops—-8,819,932USD-15,524,104USD-8,615,920USD-5,680,170USD-38,001,987USD-2,252,982USD-2,184,500USD
    Ebit—-7,055,662USD—-7,746,105USD-5,708,034USD-37,576,813USD-2,255,383USD-2,172,187USD
    Ebitda—-7,023,682USD-14,247,024USD-7,727,797USD-5,631,420USD-37,693,065USD-2,188,307USD-2,184,500USD
    Depreciation And Amortization—31,980USD—18,308USD——67,076USD—
    Reconciled Depreciation—31,980USD0USD18,308USD18,153USD0USD67,076USD67,076USD
    Source0001829126-26-008512DeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USD
    Total Revenue39,990USD83,000USD70,462USD20,000USD0USD
    Gross Profit39,990USD83,000USD70,462USD20,000USD—
    Research Development3,638,257USD3,045,239USD1,534,114USD1,163,330USD674,558USD
    Selling General Administrative42,854,372USD3,639,033USD3,396,244USD1,694,274USD2,597,125USD
    Unclassified Operating Expenses11,716,559USD—7,337,773USD——
    Total Operating Expenses58,209,188USD7,225,522USD12,268,131USD2,857,604USD3,271,683USD
    Operating Income-58,169,198USD-7,142,522USD-12,197,669USD-2,837,604USD-3,271,683USD
    Interest Income327,582USD16,133USD0USD——
    Interest Expense2,504,567USD2,702,152USD2,723,396USD200,153USD112,919USD
    Net Interest Income-3,287,469USD-2,686,019USD-2,723,396USD-200,153USD-112,919USD
    Income Before Tax-62,146,210USD-11,898,464USD-14,921,065USD-3,046,757USD-3,375,602USD
    Net Income-62,146,210USD-11,898,464USD-14,921,065USD-3,046,757USD-3,375,602USD
    Net Income From Continuing Ops-62,146,210USD-11,898,464USD-14,921,065USD-3,046,757USD-3,375,602USD
    Ebit-59,641,643USD-9,341,409USD-12,197,669USD-2,837,604USD-3,271,683USD
    Ebitda-59,605,182USD-9,095,464USD-12,197,669USD-2,846,604USD-3,262,683USD
    Depreciation And Amortization36,461USD245,945USD———
    Reconciled Depreciation36,461USD245,945USD0USD——
    Total Other Income Expense Net-3,977,012USD-4,755,942USD-2,723,396USD-209,153USD-103,919USD
    Cost Of Revenue——2,737,773USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets5,231,792USD3,330,161USD2,823,634USD4,082,916USD2,988,187USD8,441,691USD3,417,241USD2,743,806USD
    Cash And Equivalents1,973,420USD———————
    Total Current Assets4,190,280USD1,372,497USD1,388,711USD2,961,576USD1,653,942USD7,360,191USD2,195,203USD2,386,070USD
    Other Current Assets1,213,084USD1,095,649USD1,329,982USD1,448,352USD1,380,198USD1,920,981USD1,981,605USD1,051,443USD
    Total Liabilities23,761,103USD———————
    Total Current Liabilities23,506,555USD16,287,621USD20,040,681USD15,588,322USD14,476,802USD18,065,336USD8,922,202USD7,883,332USD
    Total Stockholder Equity-18,529,311USD-13,231,165USD-17,507,729USD-11,814,270USD-11,815,494USD-9,623,645USD-5,504,961USD-5,267,392USD
    Total Equity Including Noncontrolling Interest-18,529,311USD———————
    Intangible Assets481,481USD488,426USD500,000USD—————
    Accounts Payable3,439,819USD2,633,314USD7,113,185USD499,900USD3,572,860USD4,143,255USD3,521,356USD2,393,348USD
    Common Stock2,594USD2,483USD2,198USD1,948USD1,903USD1,903USD1,809USD1,809USD
    Retained Earnings-135,814,631USD-121,574,587USD-112,754,655USD-97,230,551USD-88,614,631USD-88,610,432USD-50,608,445USD-48,355,463USD
    Total Liab—16,561,326USD20,331,363USD15,897,186USD14,803,681USD18,065,336USD8,922,202USD8,011,198USD
    Other Current Liab—13,581,959USD6,904,299USD15,018,545USD10,835,309USD13,922,081USD5,376,124USD5,245,616USD
    Capital Stock—2,483USD2,198USD1,948USD1,903USD1,903USD1,809USD1,809USD
    Cash—138,601USD58,729USD1,513,224USD125,039USD5,439,210USD64,893USD1,334,627USD
    Cash And Short Term Investments—138,601USD58,729USD1,513,224USD125,039USD5,439,210USD64,893USD1,334,627USD
    Net Debt—207,452USD6,255,150USD-1,134,483USD270,473USD-5,439,210USD-40,171USD-962,393USD
    Short Term Debt—72,348USD6,023,197USD69,877USD68,633USD—24,722USD244,368USD
    Short Long Term Debt Total—346,053USD6,313,879USD378,741USD395,512USD—24,722USD372,234USD
    Net Receivables—138,247USD——148,705USD—148,705USD—
    Property Plant Equipment Net—340,639USD361,045USD379,509USD397,817USD—23,526USD357,736USD
    Property Plant Equipment Gross—340,639USD361,045USD379,509USD397,817USD—23,526USD357,736USD
    Common Stock Shares Outstanding—23,293,453shares19,211,745shares19,211,745shares19,026,776shares18,135,317shares18,745,865shares22,560,000shares
    Non Current Assets Total—1,957,663USD1,434,923USD1,121,340USD1,334,245USD1,081,500USD1,222,038USD357,736USD
    Non Current Liabilities Total—273,704USD290,682USD308,864USD326,879USD0USD-5,000USD127,866USD
    Non Currrent Assets Other—1,128,598USD573,878USD741,831USD936,428USD1,081,500USD1,198,512USD—
    Net Working Capital—-14,192,458USD-18,651,970USD-12,626,746USD-12,822,860USD-10,705,145USD-6,726,999USD-5,497,262USD
    Unclassified Equity—108,338,456USD95,242,530USD85,412,385USD76,795,331USD78,982,981USD45,099,866USD43,084,453USD
    Short Long Term Debt——5,952,066USD4,700,794USD————
    Unclassified Current Liabilities——-5,952,066USD-4,700,794USD————
    Source0001829126-26-008512DeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USD
    Total Assets2,823,634USD3,417,241USD1,265,376USD728,682USD32,491USD
    Intangible Assets500,000USD————
    Other Current Assets1,329,982USD1,981,605USD1,233,514USD95,384USD7,457USD
    Total Liab20,331,363USD8,922,202USD15,253,629USD2,304,093USD2,648,837USD
    Total Stockholder Equity-17,507,729USD-5,504,961USD-13,988,253USD-1,575,411USD-2,616,346USD
    Other Current Liab6,904,299USD5,351,402USD5,691,243USD412,500USD462,500USD
    Common Stock2,198USD1,809USD1,656USD1,050USD56,675USD
    Capital Stock2,198USD1,809USD1,656USD1,050USD59,705USD
    Retained Earnings-112,754,655USD-50,608,445USD-38,709,981USD-23,788,916USD-20,742,159USD
    Cash58,729USD64,893USD31,862USD633,298USD25,034USD
    Cash And Short Term Investments58,729USD64,893USD31,862USD633,298USD25,034USD
    Total Current Assets1,388,711USD2,195,203USD1,265,376USD728,682USD32,491USD
    Total Current Liabilities20,040,681USD8,922,202USD15,253,629USD2,304,093USD2,648,837USD
    Net Debt6,255,150USD-40,171USD6,573,595USD-583,298USD1,123,857USD
    Short Term Debt6,023,197USD49,444USD6,605,457USD50,000USD1,148,891USD
    Short Long Term Debt5,952,066USD—6,605,457USD50,000USD1,148,891USD
    Short Long Term Debt Total6,313,879USD24,722USD6,605,457USD50,000USD1,148,891USD
    Accounts Payable7,113,185USD3,521,356USD2,956,929USD1,341,593USD537,446USD
    Property Plant Equipment Net361,045USD23,526USD0USD——
    Property Plant Equipment Gross361,045USD23,526USD0USD——
    Common Stock Shares Outstanding19,211,745shares18,745,865shares18,745,865shares18,745,865shares18,745,865shares
    Non Current Assets Total1,434,923USD1,222,038USD0USD0USD0USD
    Non Current Liabilities Total290,682USD-5,000USD0USD0USD0USD
    Non Currrent Assets Other573,878USD1,198,512USD———
    Net Working Capital-18,651,970USD-6,726,999USD-13,988,253USD-1,575,411USD-2,616,346USD
    Unclassified Current Liabilities-5,952,066USD—-6,605,457USD—-1,148,891USD
    Unclassified Equity95,242,530USD45,099,866USD24,718,416USD22,211,405USD18,009,433USD
    Net Receivables—148,705USD———
    Current Deferred Revenue———500,000USD500,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Net Income-23,059,976USD
    Depreciation18,519USD
    Stock Based Compensation8,384,311USD
    Operating Cash Flow-11,756,954USD
    Investing Cash Flow0USD
    Financing Cash Flow13,671,645USD
    Change In Cash1,914,691USD
    End Cash Flow1,973,420USD
    Source0001829126-26-008512DeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-8,819,932USD-15,524,104USD-8,615,920USD-4,199USD-38,001,987USD-2,252,982USD-2,184,500USD-4,522,006USD
    Depreciation31,980USD0USD110,178USD210,402USD877,192USD67,076USD67,076USD—
    Stock Based Compensation2,732,397USD9,590,963USD5,040,246USD-2,149,895USD23,073,745USD—0USD0USD
    Other Non Cash Items3,636,361USD1,389,828USD1,500,955USD210,402USD628,276USD143,911USD0USD4,056,260USD
    Change In Working Capital-1,840,182USD952,142USD-3,844,010USD-3,370,479USD8,400,995USD1,087,591USD-969,632USD147,543USD
    Total Cash From Operating Activities-6,991,773USD-3,591,171USD-5,808,551USD-5,314,171USD-5,650,055USD-954,404USD-3,087,056USD-318,203USD
    Capital Expenditures-3USD0USD-5USD0USD-5USD-4USD0USD0USD
    Free Cash Flow-6,991,770USD-3,591,171USD-5,808,546USD-5,314,171USD-5,650,055USD-954,404USD-3,087,056USD-318,203USD
    Net Borrowings-6,666,667USD0USD4,000,000USD0USD-300,000USD0USD0USD—
    Total Cash From Financing Activities7,071,645USD2,636,676USD7,196,736USD0USD11,024,372USD-315,330USD2,889,149USD1,845,723USD
    Issuance Of Capital Stock13,738,311USD2,636,676USD3,196,736USD0USD11,324,372USD0USD2,913,121USD1,702,668USD
    Change In Cash79,872USD-954,495USD1,388,185USD-5,314,171USD5,374,317USD-1,269,734USD-197,907USD1,527,520USD
    Begin Period Cash Flow58,729USD1,513,224USD125,039USD5,439,210USD64,893USD1,334,627USD1,532,534USD5,014USD
    End Period Cash Flow138,601USD558,729USD1,513,224USD125,039USD5,439,210USD64,893USD1,334,627USD1,532,534USD
    Unclassified Operating Cash Flow-2,732,397USD———————
    Other Cashflows From Financing Activities——7,196,736USD—-300,000USD-315,330USD-23,972USD-5,650USD
    Unclassified Financing Cash Flow——-7,196,736USD—————
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USD
    Net Income-62,146,210USD-11,898,464USD-14,921,065USD-3,046,757USD-3,375,602USD
    Depreciation36,461USD245,945USD0USD——
    Stock Based Compensation35,555,059USD0USD0USD1,291,909USD2,219,333USD
    Other Non Cash Items4,052,094USD5,952,264USD11,327,295USD206,891USD103,919USD
    Change In Working Capital2,138,648USD1,486,339USD1,713,758USD666,221USD655,657USD
    Total Cash From Operating Activities-20,363,948USD-4,213,916USD-1,880,012USD-881,736USD-396,693USD
    Capital Expenditures-500,000USD-4USD0USD-4USD-3USD
    Free Cash Flow-20,863,948USD-4,213,916USD-1,880,012USD-881,736USD-396,693USD
    Total Cashflows From Investing Activities-500,000USD————
    Net Borrowings3,700,000USD100,951USD1,372,695USD-210,000USD250,000USD
    Total Cash From Financing Activities20,857,784USD4,246,947USD1,278,576USD1,490,000USD250,000USD
    Issuance Of Capital Stock17,157,784USD4,615,789USD450USD2,400,000USD0USD
    Change In Cash-6,164USD33,031USD-601,436USD608,264USD-146,693USD
    Begin Period Cash Flow64,893USD31,862USD633,298USD25,034USD171,727USD
    End Period Cash Flow58,729USD64,893USD31,862USD633,298USD25,034USD
    Other Cashflows From Financing Activities—-469,793USD-94,569USD-700,000USD—
    Change To Account Receivables———0USD82,748USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    Active NIH STTR Grants

    Period endPeriodValueUnitSource
    2026-06-30instant2countDisclosure

    Clinical Trial Expense

    Period endPeriodValueUnitSource
    2026-06-30quarter2,117,979USDDisclosure

    Laboratory Project R&D Expense

    Period endPeriodValueUnitSource
    2026-06-30quarter460,655USDDisclosure

    NEO100 Compassionate-Use Fees Received

    Period endPeriodValueUnitSource
    2026-06-30quarter20,000USDDisclosure

    NEO100-01 R&D Expense

    Period endPeriodValueUnitSource
    2026-06-30quarter998,369USDDisclosure

    NEO100-02 R&D Expense

    Period endPeriodValueUnitSource
    2026-06-30quarter304,244USDDisclosure

    NEO212 R&D Expense

    Period endPeriodValueUnitSource
    2026-06-30quarter592,757USDDisclosure

    NEO216 R&D Expense

    Period endPeriodValueUnitSource
    2026-06-30quarter75,336USDDisclosure

    Pediatric Program R&D Expense

    Period endPeriodValueUnitSource
    2026-06-30quarter147,273USDDisclosure

    Research and Laboratory Expense

    Period endPeriodValueUnitSource
    2026-06-30quarter531,694USDDisclosure

    Revenue breakdown

    No revenue breakdown is currently published for this company.

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.